Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

bmiMD vs TelePeptide

By GLP-1 ScorecardUpdated

bmiMDFactor scores not reassessed.
Site position #27

Higher score

TelePeptideFactor scores not reassessed.
Site position #296

Lower score

Score comparison

bmiMD has the higher recorded score — 79.2/100 to 62.3/100.

bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.

Before you choose

Before comparing the headline prices, the bmiMD review and the TelePeptide review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, bmiMD vs telos rx and CoreAge Rx vs TelePeptide compare each of them with another graded program, and the list of alternatives to bmiMD ranks the programs closest to bmiMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuebmiMD +44
88
44
Dose & formulationbmiMD +7
82
75
Clinical oversightTelePeptide +17
70
87
Labs & monitoringbmiMD +18
72
54
FulfillmentbmiMD +7
84
77
Contract termsbmiMD +54
74
20
bmiMD · top barTelePeptide · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricbmiMDTelePeptide
WeighScore79.2/10062.3/100
GradeC+C
Site position#27#296
Semaglutide$129/mo on the one-month plan ($99/mo equivalent with $1,188 prepaid for 12 months)$149/mo (monthly billing; $1,428 for 12 months; compounded injection)
Tirzepatide$179/mo on the one-month plan ($139/mo equivalent with $1,668 prepaid for 12 months)$249/mo (monthly billing; $2,568 for 12 months; compounded injection)
CoverageAll 50 statesCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
bmiMD

Site position #27 · C+

Factor scores not reassessed.

Strengths

  • Advertises the same price across prescribed doses for each selected injection plan
  • Publishes compounded semaglutide and tirzepatide injection plans
  • Every rung of both ladders is published with the total charge beside each per-month figure
  • All 50 states

What to consider

  • The pricing block opens on the 3-Month tab, so the figure a reader meets first is a commitment rate rather than a month
  • The annual $99 and $139 monthly equivalents require $1,188 or $1,668 paid upfront for 12 months
  • A higher $229 and $349 monthly figure is printed beside every plan price under a standing LIMITED TIME label, with no published basis
  • Neither the compounding pharmacy nor the prescribing group is named on the product pages
TelePeptide

Site position #296 · C

Factor scores not reassessed.

Strengths

  • LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
  • All-inclusive from about $119/mo on a 12-month plan ($1,428) — physician eval, Rx, medication and shipping
  • Publishes 1-, 3-, 6- and 12-month prices for both injections
  • 24/7 care team messaging + regular check-ins + dosage adjustments included at every tier
  • 48 states + DC coverage (excludes only AK + MS); no insurance required; cancel anytime

What to consider

  • Compounded medications are not FDA-approved; no pharmacy partner named publicly
  • Monthly billing costs more — $149/mo versus about $119/mo on the 12-month plan for semaglutide; the best rate requires annual prepay
  • Labs not included in any plan
  • Founder disclosed by first name only (Ahmed); no physician names or clinical leadership disclosed publicly
  • Tirzepatide injectable at $249/mo (monthly billing) is above the compounded market average

Featured provider

bmiMD

Factor scores not reassessed.

bmiMD scores 79.2/100 (C+). bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard